Dark Forest Capital Management LP Regenxbio Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $158,015 - $319,536	12,984 New	12,984 $273,000
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $239,738 - $302,072	13,914 Added 109.21%	26,655 $532,000
Q1 2023 May 12, 2023	BUY	$18.08 - $24.55 $230,357 - $312,791	12,741 New	12,741 $240,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $54,120 - $85,077	2,428 Added 26977.78%	2,437 $64,000
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $174 - $315	9 New	9 $0

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.